Delivery Order SPE2DB22D1106-SPE2DB24FEDL3
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $3.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the provision of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) by prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The firm fixed price delivery order has a potential value of $7,315.70 and a performance period through March 4, 2024. The contract does not utilize any set-aside designations. Amerisourcebergen Drug Corp is an experienced government contractor, holding an indefinite delivery contract...
- This federal contract award is for the delivery of 4,563,760,076 tablets of Ondansetron ODT 4 mg to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The firm fixed price delivery order has a potential value of $4,115.65 and a completion date of February 26, 2024. No set-aside designation was used for this...
- This federal contract award is for the delivery of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price of $4,338.75 and has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $7,497.72 and a completion date of February 2, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite...
- This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various government agencies. The contract has a ceiling value of $3,764.69 and is a firm-fixed-price delivery order with an ultimate...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the provision of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $78,266.61. It does not have a Set-Aside designation, indicating open competition. The contract has an Ultimate Completion Date of December 18, 2024 and was awarded on December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a completion date of February 26, 2024 and a potential value of $2,571.12. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...